Table 3.
Laboratory data of the patients prior to starting of immune therapy
| Variables | Total (n = 199) | Discharged (n = 122) | Expired (n = 77) | Difference (95% CI) | p-value |
|---|---|---|---|---|---|
| Baseline hemato-biochemical profiles# | |||||
| Percentage of neutrophils, median (IQR) | 87 (82-90) | 87 (82-90) | 85 (80-90) | 3.06 (0.10-6.6.01) | <0.05 |
| Percentage of lymphocytes, median (IQR) | 9 (6-13) | 9 (6-12) | 10 (6-16) | 3.11 (0.46-5.76) | <0.05 |
| D-dimer (pg/mL), median (IQR) | 0.72 (0.48-0.95) | 0.74 (0.48-1.08) | 0.68 (0.49-0.84) | 0.23 (0.03-0.43) | <0.05 |
| Lactate dehydrogenase (U/L), median (IQR) | 986 (786-1352) | 980 (831-1224) | 986 (768-1568) | 50.26 (-69.8 to 170.3) | 0.409 |
| C-reactive protein (mg/L), median (IQR) | 12.0 (6.0-12.0) | 12.0 (12.0-12.0) | 12.0 (6.0-24.0) | 0.94 (-0.81 to 2.69) | 0.297 |
The values are shown based on available data;
#
neutrophil normal range 40 to 70% of WBC; lymphocyte normal range 20 to 40% of WBC; D-dimer normal value ≤0.05 μg/mL; lactate dehydrogenase normal range 135 to 480 U/L; C-reactive protein normal value ≤10.0 mg/L; CI, confidence interval; IQR, interquartile range